HMC provides novel treatment for allergic disorders
The Peninsula
Hamad Medical Corporation (HMC) has introduced new advanced treatment for several allergic disorders as it aspires to provide first-class service to the population of Qatar in line with international standards.
‘Biologics’, different from traditional systemic drugs, are being used for patients with allergic disorders such as asthma and urticaria.
“At present we are in the era of precision medicine or targeted treatment. Biologic medications have been major breakthroughs for the treatment of various allergic disorders like asthma, urticaria, atopic dermatitis and chronic rhinitis with nasal polyposis.
Qatar sets benchmark in oncology education, hosting first-ever ESMO Advanced Course on Breast Cancer
Doha, Qatar: Hamad Medical Corporation (HMC) continues to play a vital role in enhancing healthcare in Qatar by hosting the ESMO Advanced Course on Br...
Qatar sets benchmark in oncology education, hosting first-ever ESMO Advanced Course on Breast Cancer
Doha, Qatar: Hamad Medical Corporation (HMC) continues to play a vital role in enhancing healthcare in Qatar by hosting the ESMO Advanced Course on Br...